Align Technology gears up to enter China market
Align Technology has received regulatory approval from the Chinese State Food and Drug Administration to market and sell the Invisalign system as a class II medical device for the treatment of malocclusion, the company announced. Align also received its License of Medical Device Operation Enterprise (Enterprise License) from the Shanghai Food and Drug Administration, which allows the company to distribute Invisalign in China. Align expects to begin commercial availability of

